Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) today announced a subcommittee hearing titled “Protecting American Health Security: Oversight of Shortcomings in the FDA's Foreign Drug Inspection Program.”

“The FDA’s oversight and enforcement of manufacturing practices have long stood as the gold standard for ensuring Americans can trust the safety and efficacy of prescription drugs and medical devices. However, in recent years, the agency has largely scaled back its foreign manufacturing facility inspection program, raising concerns about whether food, drugs, and medical devices are being made in safe and secure conditions,” said Chairs Rodgers and Griffith. “This hearing, which builds upon our ongoing investigations, will give Members a chance to discuss the importance of the FDA’s foreign inspection program, why it hasn’t been widely restarted in countries like India and China, and how this trend affects domestic production.” 

Subcommittee on Oversight and Investigations hearing titled "Protecting American Health Security: Oversight of Shortcomings in the FDA's Foreign Drug Inspection Program.”  

WHAT: A subcommittee hearing to discuss oversight of the Food and Drug Administration’s (FDA) foreign inspections program.  

DATE: Tuesday, February 6, 2024     

TIME: 10:30 AM ET    

LOCATION: 2322 Rayburn House Office Building     

WITNESSES: Witnesses will be announced and are by invitation only.  

This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at https://energycommerce.house.gov/. If you have any questions concerning the hearing, please contact Lauren Kennedy and Noah Jackson with the Committee staff at Lauren.Kennedy@mail.house.gov and Noah.Jackson@mail.house.gov. If you have any press-related questions, please contact Christopher Krepich at Christopher.Krepich@mail.house.gov.